Glaucoma-associated adverse events common in pediatric eyes after lensectomy
Click Here to Manage Email Alerts
Key takeaways:
- Glaucoma-related adverse events are common in children after lensectomy.
- Aphakia and age younger than 3 months are associated with a higher risk.
Glaucoma-related adverse events are frequent after lensectomy in children, according to a study.
Aphakia and age younger than 3 months were associated with a higher risk, while the risk was lower in older children with pseudophakia.
The study used longitudinal registry data collected annually for 5 years by the Pediatric Eye Disease Investigator Group at 45 institutional sites and 16 community sites. A total of 1,049 eyes of 810 children were included; 443 eyes of 321 children were aphakic after lensectomy, and 606 eyes of 489 children were pseudophakic. Most aphakic eyes were in children younger than 6 months.
The cumulative incidence of glaucoma-related adverse events after 5 years was 29% in the group of aphakic eyes and 7% in the group of pseudophakic eyes. These events were more common among aphakic eyes when lens surgery was performed within the first 6 weeks of life (44%) and between 6 weeks and 3 months of age (35%).
Other studies have identified the first 3 months of life as the highest risk period for the development of glaucoma following lensectomy, the authors noted, recommending caution when considering cataract surgery at this early age.
Over the time span of 5 years, 33 aphakic eyes (7%) and three pseudophakic eyes (0.5%) required glaucoma surgery.
“The high incidence of glaucoma-related adverse events in aphakic and pseudophakic eyes found in this study suggests the need for close monitoring for glaucoma after lensectomy,” the authors said.
References:
- Bothun ED, et al. Ophthalmology. 2019;doi:10.1016/j.ophtha.2019.03.011.
- Bothun ED, et al. Ophthalmology. 2021;doi:10.1016/j.ophtha.2020.07.020.
- Freedman SF, et al. JAMA Ophthalmol. 2015;doi:10.1001/jamaophthalmol.2015.1329.
- Freedman SF, et al. JAMA Ophthalmol. 2021;doi:10.1001/jamaophthalmol.2020.5664.
- Nyström A, et al. Acta Ophthalmol. 2020;doi:10.1111/aos.14414.
- Solebo AL, et al. Br J Ophthalmol. 2020;doi:10.1136/bjophthalmol-2019-314804.